🔬 Science
Today's top 5 stories, curated by Daily Direct.
The amyloid hypothesis for treating Alzheimer's is taking a serious hit. A major review of over 20,000 participants found that amyloid-clearing drugs offer no meaningful clinical benefit to patients. Worse, they appear to raise the risk of brain swelling and bleeding — complications that can occur silently, making them harder to detect and manage.
Read article →Evolution may be less chaotic than scientists once assumed. A new study reveals that distantly related butterflies and moths have repeatedly drawn on the same two genes over 120 million years to produce nearly identical warning color patterns. Rather than rewriting the genetic code itself, evolution tweaks the regulatory switches that control these genes — suggesting that life converges on the same molecular solutions with surprising consistency.
Read article →California's Chinook salmon are vanishing before they ever reach the ocean, decimated by a brutal cycle of drought and flooding that has turned river migration into a death trap. A new study from the University of Essex, NOAA Fisheries, UC Davis, and Cramer Fish Sciences found that extreme weather events are compounding the damage done by decades of wetland destruction, stripping young salmon of the habitats they need to survive. Researchers warn the losses are unprecedented, with implications that extend far beyond California's rivers.
Read article →Users of GLP-1 drugs like Ozempic and Wegovy may be getting more than they bargained for — in the best possible way. A study of nearly 100,000 patients found the medications were linked to significantly fewer psychiatric hospital visits and sick days over more than a decade. The findings add to growing evidence that these drugs could have wide-ranging benefits well beyond blood sugar control and weight loss.
Read article →Researchers have found that arginine, a common and inexpensive amino acid, can significantly reduce the toxic amyloid protein buildup associated with Alzheimer's disease. In animal studies, oral supplementation lowered harmful deposits, eased brain inflammation, and improved behavioral outcomes. The compound's established safety profile makes it a compelling candidate for further clinical investigation.
Read article →Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →